Literature DB >> 22344673

Utility of positron-emission tomography/computed tomography imaging in the management of the neck in recurrent laryngeal cancer.

Mark R Gilbert1, Barton F Branstetter, Seungwon Kim.   

Abstract

OBJECTIVES/HYPOTHESIS: Patients who develop recurrence of laryngeal cancer after radiotherapy organ preservation protocols are offered salvage laryngectomy, often with bilateral neck dissection. However, there can be multiple complications of neck dissection in the previously irradiated neck, including poor wound healing and increased potential for fistula. Positron-emission tomography/computed tomography (PET/CT) may have the ability to spare some of these patients from the morbidity of unnecessary neck dissections if it can reliably exclude recurrent nodal disease. The purpose of our study was to determine whether preoperative PET/CT could correctly predict the pathologic status of the neck in patients with locally recurrent laryngeal cancer and clinically N0 neck. STUDY
DESIGN: Retrospective review.
METHODS: A review of our head and neck tumor registry revealed 269 patients with recurrence of laryngeal cancer from 1975 to 2010. Out of this pool, we identified 15 patients who had PET/CT scans prior to neck dissections for recurrent laryngeal cancer.
RESULTS: Five patients with pathologically negative neck had accurate PET/CT reads (100% specificity) prior to surgery. Similarly, seven patients who had a PET/CT read positive for cervical disease had pathologically positive nodes (100% positive predictive value). However, three patients with clinically N0 neck who had PET/CT reads that were negative had positive nodal pathology, giving a sensitivity of 70% and a 62.5% negative predictive value.
CONCLUSIONS: We believe that this false negative rate is too high to warrant deferring neck dissection based on PET/CT, and we recommend that patients who are clinically N0 for recurrent laryngeal cancer be offered neck dissection along with salvage laryngectomy.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22344673     DOI: 10.1002/lary.22428

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?

Authors:  A Gore; K Baugnon; J Beitler; N F Saba; M R Patel; X Wu; B J Boyce; A H Aiken
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-18       Impact factor: 3.825

Review 2.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

3.  Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.

Authors:  D A Krieger; P A Hudgins; G K Nayak; K L Baugnon; A S Corey; M R Patel; J J Beitler; N F Saba; Y Liu; A H Aiken
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-31       Impact factor: 3.825

4.  Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.

Authors:  Andrew Rosko; Andrew Birkeland; Andrew Shuman; Mark Prince; Carol Bradford; Gregory Wolf; Francis Worden; Avraham Eisbruch; Ashok Srinivasan; Ka Kit Wong; Matthew E Spector
Journal:  Head Neck       Date:  2017-02-25       Impact factor: 3.147

5.  Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma.

Authors:  G Pedemonte; E Esteller; J-C Villatoro; J-M Costa; C Valero; M Quer; X León
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.